These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21392671)

  • 21. [Glucocorticoid and bone].
    Soen S
    Clin Calcium; 2014 Jun; 24(6):829-36. PubMed ID: 24870833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study.
    Okamoto K; Inaba M; Furumitsu Y; Ban A; Mori N; Yukioka K; Imanishi Y; Nishizawa Y
    Life Sci; 2010 Dec; 87(23-26):686-91. PubMed ID: 20951147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.
    Borah B; Dufresne TE; Ritman EL; Jorgensen SM; Liu S; Chmielewski PA; Phipps RJ; Zhou X; Sibonga JD; Turner RT
    Bone; 2006 Aug; 39(2):345-52. PubMed ID: 16571382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of prednisolone-induced osteoporosis on bone mass and bone quality of the mandible in rats.
    Kozai Y; Kawamata R; Sakurai T; Kanno M; Kashima I
    Dentomaxillofac Radiol; 2009 Jan; 38(1):34-41. PubMed ID: 19114422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
    Rauch F; Munns CF; Land C; Cheung M; Glorieux FH
    J Bone Miner Res; 2009 Jul; 24(7):1282-9. PubMed ID: 19257821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risedronate: clinical usage.
    Chapurlat RD; Delmas PD
    Int J Clin Pract; 2001 May; 55(4):275-8. PubMed ID: 11406915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.
    Shomali T; Rezaian M; Rassouli A; Asadi F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):46-50. PubMed ID: 19302435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible.
    Mahl CR; Fontanella V
    Dentomaxillofac Radiol; 2008 Dec; 37(8):438-44. PubMed ID: 19033428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of steroid-induced osteoporosis on osseointegration of titanium implants.
    Fujimoto T; Niimi A; Sawai T; Ueda M
    Int J Oral Maxillofac Implants; 1998; 13(2):183-9. PubMed ID: 9581403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.
    Allen MR; Follet H; Khurana M; Sato M; Burr DB
    Calcif Tissue Int; 2006 Oct; 79(4):255-61. PubMed ID: 17033724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.
    Boonen S; Orwoll ES; Wenderoth D; Stoner KJ; Eusebio R; Delmas PD
    J Bone Miner Res; 2009 Apr; 24(4):719-25. PubMed ID: 19049326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permanent reduction of mandibular size and bone stiffness induced in post-weaning rats by cyclophosphamide.
    Olivera MI; Martínez MP; Conti MI; Bozzini C; Bozzini CE; Alippi RM
    Arch Oral Biol; 2009 Jan; 54(1):6-11. PubMed ID: 18814858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
    Hasegawa M; Nisikawa M; Nomura S; Takubo T; Suehiro A; Saigo K; Hayashi K; Tamaki S; Mizutani M; Uemura Y; Kurata Y;
    Rinsho Ketsueki; 2005 Feb; 46(2):121-6. PubMed ID: 16447705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid-induced osteoporosis: hope on the HORIZON.
    Gennari L; Bilezikian JP
    Lancet; 2009 Apr; 373(9671):1225-6. PubMed ID: 19362657
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of masticatory muscle function and bite-raising on mandibular morphology in the growing rat.
    Bresin A
    Swed Dent J Suppl; 2001; (150):1-49. PubMed ID: 11803646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats.
    Díaz-Curiel M; de la Piedra C; Romero FI; Montero M; Gómez S; Lefort M; Carrascal MT; Phipps RJ
    Horm Res; 2008; 70(2):93-9. PubMed ID: 18547956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.